Contract drug maker Divi's misses profit view on high material costs ...Middle East

The Hyderabad-based company's consolidated net profit marginally fell to ₹583 crore ($64.31 million) in the quarter ended December 31, from ₹589 crore a year earlier

Hence then, the article about contract drug maker divi s misses profit view on high material costs was published today ( Wednesday 11/02/2026 - 12:36 PM ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Contract drug maker Divi's misses profit view on high material costs )

Also on site :

• Money Talks: This Season on ‘Industry’
• OSRS Leagues 6: Demonic Pacts release date, rewards and what to expect
• ‘I graduated with £84k student loan debt – I’ve applied for 60 jobs but can only get a part-time shop role’